Richard Francis Salary and Compensation - TEVA PHARMACEUTICAL INDUSTRIES LTD CEO Salary 2025

In fiscal year 2025, Richard Francis, President and Chief Executive Officer of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), received total compensation of $19.2 million.

Richard Francis's compensation breakdown includes: base salary of $1.7 million, stock awards valued at $12.0 million, non-equity incentive compensation of $4.8 million, and other compensation of $641K.

Compared to fiscal year 2024, Richard Francis's total compensation increased 24% from $15.5 million to $19.2 million.

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Executive Pay 2025

TEVA PHARMACEUTICAL INDUSTRIES LTD's top 5 named executive officers received combined total compensation of $45.5 million in fiscal year 2025.

The named executive officers disclosed in TEVA PHARMACEUTICAL INDUSTRIES LTD's 2025 proxy statement are:Richard Francis (President and Chief Executive Officer) with total compensation of $19.2 million, Evan Lippman (Executive Vice President Business Development) with total compensation of $7.2 million, Eli Kalif (Executive Vice President Chief Financial Officer) with total compensation of $7.0 million, Eric Hughes (Executive Vice President Global R&D and Chief Medical Officer) with total compensation of $6.3 million, and Christine Fox (Executive Vice President US Commercial) with total compensation of $5.9 million.